160 related articles for article (PubMed ID: 1687348)
1. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
[TBL] [Abstract][Full Text] [Related]
4. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
[TBL] [Abstract][Full Text] [Related]
5. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine.
Tasaka K; Kamei C; Izushi K; Tsujimoto S; Yoshida T
Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
Tasaka K; Kamei C; Nakamura S
Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
[TBL] [Abstract][Full Text] [Related]
8. [Effects of ferulic acid on allergic reaction].
Hu HJ; Hang BQ
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):426-30. PubMed ID: 1840284
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
Omote M; Sakai K; Mizusawa H
Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
Mita H; Shida T
Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.
Tomioka K; Yamada T; Mase T; Murase K
Pharmacology; 1989; 39(1):28-38. PubMed ID: 2531424
[TBL] [Abstract][Full Text] [Related]
12. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
[TBL] [Abstract][Full Text] [Related]
13. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
Terasawa M; Goto K; Maruyama Y
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
[TBL] [Abstract][Full Text] [Related]
14. [Effect of KC-404 on allergic reactions types I-IV].
Nishino K; Hara S; Irikura T
Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
Fügner A; Bechtel WD; Kuhn FJ; Mierau J
Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
[TBL] [Abstract][Full Text] [Related]
16. Roxithromycin inhibits the effector phase of delayed-type hypersensitivity.
Liu K; Xu Q
Int Immunopharmacol; 2008 Jan; 8(1):126-31. PubMed ID: 18068108
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic modulation of delayed-type hypersensitivity in mice.
Yamada N; Sugasawa K
Arzneimittelforschung; 1996 Sep; 46(9):884-6. PubMed ID: 8876937
[TBL] [Abstract][Full Text] [Related]
18. Anti-allergic action of glucocorticoids (II). Effect of glucocorticoids on cell mediated (type IV) allergic reactions.
Nagai H; Takizawa T; Inagaki N; Sakamoto T; Shimazawa T; Koda A
Arerugi; 1989 Jun; 38(6):493-500. PubMed ID: 2589982
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of granulocytes in the lung and skin of guinea pigs. Inhibition by the anti-H1 antiallergic agent epinastine.
Fügner A; Meissner C
Arzneimittelforschung; 1994 Dec; 44(12):1338-42. PubMed ID: 7848354
[TBL] [Abstract][Full Text] [Related]
20. [Anti-allergic effects of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole fumarate (KB-2413)].
Saito T; Nishimura N; Tajima S; Fukuda T; Ito K
Nihon Yakurigaku Zasshi; 1987 Feb; 89(2):55-62. PubMed ID: 2883094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
